From 2028 to 2032, gener­ic drug ap­pli­cants will con­tin­ue to see many of the same FDA re­view time­lines as they did over the last five...

Pres­i­dent Don­ald Trump fur­ther as­sert­ed con­trol over the na­tion’s child­hood vac­cine sched­ule, call­ing for the measles, mumps and rubel­la (MMR) vac­cine to split in­to three...

A fed­er­al judge has sus­pend­ed the Pen­tagon's des­ig­na­tion of WuXi AppTec as a com­pa­ny with al­leged ties to the Chi­nese mil­i­tary.

Judge James Boas­berg wrote...

The FDA will host an ad­vi­so­ry com­mit­tee meet­ing in Sep­tem­ber to re­view Grail's con­tro­ver­sial can­cer test that failed to meet the pri­ma­ry end­point of a...

As the de­bate rolls on over how the US can bet­ter com­pete with Chi­na on drug de­vel­op­ment, the FDA is de­tail­ing plans for an ex­pe­dit­ed...

Mod­er­na may be pub­licly piv­ot­ing to­ward its can­cer ther­a­pies, but it's still notch­ing new vac­cine ap­provals along the way.

The lat­est reg­u­la­to­ry ap­provalcame well...